113 related articles for article (PubMed ID: 18287947)
21. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
Trouw LA; Nielsen HM; Minthon L; Londos E; Landberg G; Veerhuis R; Janciauskiene S; Blom AM
Mol Immunol; 2008 Aug; 45(13):3649-60. PubMed ID: 18556068
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons.
Goldsbury C; Whiteman IT; Jeong EV; Lim YA
Aging Cell; 2008 Oct; 7(5):771-5. PubMed ID: 18691184
[TBL] [Abstract][Full Text] [Related]
23. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
24. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells.
Kazmierczak A; Strosznajder JB; Adamczyk A
Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein J (clusterin) and Alzheimer's disease.
Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of alpha-, beta- and gamma-secretase expression.
Quiroz-Baez R; Rojas E; Arias C
Neurochem Int; 2009 Dec; 55(7):662-70. PubMed ID: 19560504
[TBL] [Abstract][Full Text] [Related]
27. Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen.
Tucker HM; Kihiko-Ehmann M; Estus S
J Neurosci Res; 2002 Oct; 70(2):249-55. PubMed ID: 12271474
[TBL] [Abstract][Full Text] [Related]
28. Potential therapeutic implications of gelsolin in Alzheimer's disease.
Ji L; Zhao X; Hua Z
J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
[TBL] [Abstract][Full Text] [Related]
29. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.
Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT
Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress induces intralysosomal accumulation of Alzheimer amyloid beta-protein in cultured neuroblastoma cells.
Zheng L; Roberg K; Jerhammar F; Marcusson J; Terman A
Ann N Y Acad Sci; 2006 May; 1067():248-51. PubMed ID: 16803994
[TBL] [Abstract][Full Text] [Related]
31. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
[TBL] [Abstract][Full Text] [Related]
32. Endosomal accumulation of GM1 ganglioside-bound amyloid beta-protein in neurons of aged monkey brains.
Kimura N; Yanagisawa K
Neuroreport; 2007 Oct; 18(16):1669-73. PubMed ID: 17921865
[TBL] [Abstract][Full Text] [Related]
33. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.
Aoki M; Volkmann I; Tjernberg LO; Winblad B; Bogdanovic N
Neuroreport; 2008 Jul; 19(11):1085-9. PubMed ID: 18596605
[TBL] [Abstract][Full Text] [Related]
34. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment.
Hernández-Guillamon M; Delgado P; Ortega L; Pares M; Rosell A; García-Bonilla L; Fernández-Cadenas I; Borrell-Pagès M; Boada M; Montaner J
J Neurosci Res; 2009 Jul; 87(9):2115-25. PubMed ID: 19235898
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
36. Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity.
Paula-Lima AC; Tricerri MA; Brito-Moreira J; Bomfim TR; Oliveira FF; Magdesian MH; Grinberg LT; Panizzutti R; Ferreira ST
Int J Biochem Cell Biol; 2009 Jun; 41(6):1361-70. PubMed ID: 19130896
[TBL] [Abstract][Full Text] [Related]
37. Anti-amyloidogenic activity of S-allyl-L-cysteine and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.
Gupta VB; Rao KS
Neurosci Lett; 2007 Dec; 429(2-3):75-80. PubMed ID: 18023978
[TBL] [Abstract][Full Text] [Related]
38. Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes.
Ito S; Ohtsuki S; Kamiie J; Nezu Y; Terasaki T
J Neurochem; 2007 Dec; 103(6):2482-90. PubMed ID: 17908238
[TBL] [Abstract][Full Text] [Related]
39. Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of Down syndrome subjects.
Ji L; Chauhan V; Mehta P; Wegiel J; Mehta S; Chauhan A
J Alzheimers Dis; 2010; 22(2):609-17. PubMed ID: 20847428
[TBL] [Abstract][Full Text] [Related]
40. Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brain in vivo.
Kaminsky YG; Kosenko EA
Free Radic Res; 2008 Jun; 42(6):564-73. PubMed ID: 18569014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
